Ann: Results of Meeting, page-8

I understand your comment, however I respectfully disagree, in general terms. I don't believe it is possible for anything said on hotcopper to affect the price in any meaningful way. Imugene has 20'001 shareholders as per the annual report, I would be surprised if hotcopper had even 1000 of those as regular forum readers. Technically the price has room to test 0.495 and if we do it's not likely to be because of any comment on a forum, in my opinion. It's far more likely any price drop is due to Axel being a giant in immunotherapy. We'll have to see what the implications of this vote failure are. It simply may not be a big deal.

75% needed to pass. It didn't.